World Market for Needle-Free Drug Delivery Systems to 2020 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "The Market for Needle-Free Drug Delivery Systems" report to their offering.

Vaccine administration is a focal point of needle-free drug delivery. Providing the needed vaccines in remote areas where there are limited healthcare personnel is a goal of needle-free vaccine administration. In addition, the use of needle-free technology in the pediatric population is becoming an increasingly useful method of delivery for children, who generally require many vaccines in the early years.

One of the most significant drivers of the needle-free drug delivery market is the rise in the number of biopharmaceuticals. Biopharmaceuticals have shown great promise in treating various diseases and are considered standard of care in some cases. However, most biologics are administered by injection. Needle-free administration provides a cost-effective, easy to use, safe method to administer biologics without the need for traditional injection apparatus or trained personnel.

Specific data in the report includes:

  • Market Estimate and Forecast for Jet Technology,
  • Market Estimate and Forecast for Other Needle-Free
  • Insulin Needle-Free Delivery Market
  • Vaccine Needle-Free Delivery Market
  • Pediatric Needle-Free Delivery Market
  • Pain Needle-Free Delivery Market
  • Cost per Million Injections by Injector Type
  • Seven Important Conclusions About the Market
  • Profiles of Injectable/Implantable and Needle-Free Drug Delivery Companies

Key Topics Covered:



  • Technology
  • Needle-free Injection Technology
  • Types of Needle-free Injection Technology Systems
  • Jet-based Needle-free Injectors
  • Spring-based Needle-free Injectors
  • Laser-based Needle-free Injectors
  • Products
  • Other Needle-free Technology
  • Transdermal Technology
  • Microneedles
  • Nanopatches
  • Novel Needle-free Technology
  • Intranasal
  • Electronically Assisted Transport
  • Iontophoresis
  • Applications
  • Insulin Needle-free Drug Delivery
  • Vaccine Needle-free Drug Delivery
  • Pediatric Needle-free Drug Delivery
  • Pain Needle-free Drug Delivery
  • Other Needle-free Drug Delivery


  • Pen Injectors
  • Biologics Including Biosimilars
  • Novel Vaccine Delivery Development
  • Edible Vaccines
  • Mucosal Delivery
  • Intranasal Delivery
  • Vaccine Patches
  • Vaccine Chips
  • Delivery Systems Placement Trends
  • Nanotechnology
  • Drug Delivery Development
  • DNA Vaccines
  • Needle-Free Delivery Development
  • Selected Products in Development
  • Ultrasonic Patch Delivery
  • Paradigm Shift
  • Bolus Injectors
  • Smart Injectors



  • Advantages of Needle-free Drug Delivery
  • Drivers of the Needle-free Drug Delivery Market
  • Biologics
  • Cancer
  • Home Care


  • Conclusion 1: Product Exclusivity Can Be Extended by Novel Drug Delivery
  • Conclusion 2: Novel Drug Delivery Leads To Differentiation of Products
  • Conclusion 3: Needle-free Drug Delivery Augments Vaccine Sales, Availability and Use
  • Conclusion 4: Needle-free Devices Need To Be More Cost Effective
  • Conclusion 5: Biotech Drug Developers Will Benefit From Needle-free Delivery
  • Conclusion 6: Home Care Trend Driving Needle-free Drug Delivery Growth


  • 3M Pharmaceuticals
  • Akra Dermojet
  • Antares Pharma, Inc.
  • Becton Dickinson and Company
  • Bioject Medical Technologies, Inc.
  • Crossject SA
  • D'Antonio Consultants International, Inc
  • Glide Pharma Technologies Limited
  • Injex Pharma AG
  • Inovio Pharmaceuticals, Inc.
  • Medical International technologies, Inc
  • MedImmune, Inc
  • Mystic Pharmaceuticals, Inc
  • National Medical Products, Inc
  • Optinose, Inc
  • Pharmajet, Inc
  • PowderMed, Inc/Pfizer
  • Valeritas, Inc
  • Zogenix, Inc

For more information about this report visit

Related Topics: Healthcare, Drug Delivery


Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716